ARKG vs TECL

ARK Genomic Revolution ETF vs Direxion Daily Technology Bull 3X ETF

Quick take
  • ARKG has the lower expense ratio at 0.75% vs 0.87% for TECL.
  • TECL pays a higher dividend yield (3.62%).

Side-by-side metrics

MetricARKGTECL
Expense ratio
Annual fee. Lower is better.
0.75%0.87%
Dividend yield
Trailing 12-month yield.
0.00%3.62%
AUM
Assets under management — bigger funds are typically more liquid.
$1.73B$6.67B
YTD return
44.53%68.28%
1-year return
3-year return
Annualized.
5-year return
Annualized.
10-year return
Annualized.
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
2.384.86
P/E ratio
31.97
Last price
$43.00$209.97
Inception
Issuer
ARKDirexion

ARKG top holdings

Top holdings · ARKG
TWSTTwist Bioscience Corp9.15%
TEMTempus AI Inc Class A common stock7.64%
ABSIAbsci Corp7.01%
TXG10x Genomics Inc Ordinary Shares - Class A7.00%
CRSPCRISPR Therapeutics AG6.56%
PSNLPersonalis Inc6.19%
BEAMBeam Therapeutics Inc4.34%
GHGuardant Health Inc4.28%
NTRANatera Inc4.11%
ILMNIllumina Inc3.98%
Sector breakdown · ARKG
Healthcare100.0%

TECL top holdings

Top holdings · TECL
NVDANVIDIA Corp9.37%
AAPLApple Inc8.22%
MSFTMicrosoft Corp5.36%
MUMicron Technology Inc3.47%
Sector breakdown · TECL
Technology99.2%
Communication Services0.8%

About ARKG

ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology. Managed by ARK, the fund carries $1.7B in assets under management, an expense ratio of 0.75%. Its largest holding is Twist Bioscience Corp (TWST), which represents 9.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.

About TECL

TECL (Direxion Daily Technology Bull 3X ETF) is 3x daily performance of the S&P tech sector. Managed by Direxion, the fund carries $6.7B in assets under management, an expense ratio of 0.87%, a dividend yield of 3.62%. Its largest holding is NVIDIA Corp (NVDA), which represents 9.4% of the portfolio. Technology is the fund's largest sector exposure at 99.2%.